These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 1463093)

  • 41. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.
    Rosenberg AE; Nielsen GP; Keel SB; Renard LG; Fitzek MM; Munzenrider JE; Liebsch NJ
    Am J Surg Pathol; 1999 Nov; 23(11):1370-8. PubMed ID: 10555005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-grade myxoid chondrosarcoma of the temporal bone: differential diagnosis and report of two cases.
    Reid CB; Fagan PA; Turner J
    Am J Otol; 1994 May; 15(3):419-22. PubMed ID: 8579153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skull Base Chordomas and Chondrosarcomas.
    Kremenevski N; Schlaffer SM; Coras R; Kinfe TM; Graillon T; Buchfelder M
    Neuroendocrinology; 2020; 110(9-10):836-847. PubMed ID: 32541136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis.
    Miettinen M
    Arch Pathol Lab Med; 1984 Nov; 108(11):891-2. PubMed ID: 6548365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chordomas and chordoma-like neoplasms].
    Gmür W; von Hochstetter AR
    Pathologe; 1988 Sep; 9(5):268-75. PubMed ID: 2845386
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunohistochemical studies of chordomas and choroid tumors].
    Lossnitzer A; Zotter S; Kunze KD
    Zentralbl Allg Pathol; 1986; 132(3):193-6. PubMed ID: 2431555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chordomas of the mediastinum: clinicopathologic, immunohistochemical, and ultrastructural study of six cases presenting as posterior mediastinal masses.
    Suster S; Moran CA
    Hum Pathol; 1995 Dec; 26(12):1354-62. PubMed ID: 8522309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. INSM1 Expression in Chordomas.
    Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
    Am J Clin Pathol; 2021 Aug; 156(3):334-339. PubMed ID: 33629710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas.
    Costa MJ; Morris RJ; Wilson R; Judd R
    Hum Pathol; 1992 Jul; 23(7):787-97. PubMed ID: 1612579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative squash and touch cytology of chondroid chordoma of the skull base. Report of a case with immunocytochemical and immunohistochemical studies.
    Nabeshima K; Sato S; Sameshima T; Goya T; Ohno A; Hinoura Y; Koono M
    Acta Cytol; 1997; 41(3):913-8. PubMed ID: 9167726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Notochordal tumors : Benign notochordal tumors and chordomas].
    Barth TFE; von Witzleben A; Möller P; Scheil-Bertram S
    Pathologe; 2018 Mar; 39(2):117-124. PubMed ID: 29236139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases.
    Hoch BL; Nielsen GP; Liebsch NJ; Rosenberg AE
    Am J Surg Pathol; 2006 Jul; 30(7):811-8. PubMed ID: 16819322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity.
    Mori K; Chano T; Kushima R; Hukuda S; Okabe H
    Virchows Arch; 2002 Feb; 440(2):123-127. PubMed ID: 11964040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
    Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
    J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.
    Vuong HG; Dunn IF
    World Neurosurg; 2022 Jun; 162():e635-e639. PubMed ID: 35339711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decisive role of immunocytochemistry in aspiration cytology of chordoma of the clivus: a case report with review of the literature.
    Gherardi G; Marveggio C; Cola C; Redaelli G
    J Laryngol Otol; 1994 May; 108(5):426-30. PubMed ID: 8035126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma.
    Arai M; Nobusawa S; Ikota H; Takemura S; Nakazato Y
    Brain Tumor Pathol; 2012 Oct; 29(4):201-6. PubMed ID: 22323113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of tau proteins and tubulin in extraskeletal myxoid chondrosarcoma, chordoma, and other chondroid tumors.
    Hu B; McPhaul L; Cornford M; Gaal K; Mirra J; French SW
    Am J Clin Pathol; 1999 Aug; 112(2):189-93. PubMed ID: 10439798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.